Physician profile
Paul A Shutter
NPI 1376200691
$2,157.47
in general payments reported to CMS, 2019-2025
15 companies · $1,236 in 2025
The $1,236 reported for 2025 was more than what 88% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $399 · 2023: $256 · 2024: $267 · 2025: $1,236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,074 · Travel and Lodging: $685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,073.60 |
| Travel and Lodging | $685.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $892.69 | 2022-2025 | Barostim Neo System |
| Medtronic, INC. | $312.53 | 2024-2025 | Corevalve Evolut R |
| Boston Scientific Corporation | $189.14 | 2023-2024 | Watchman Access System, Watchman Flx |
| Amgen INC. | $168.39 | 2022-2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $149.91 | 2025 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $124.50 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $60.40 | 2022-2025 | Wainua |
| Lexicon Pharmaceuticals, INC. | $57.53 | 2023 | Inpefa |
| Scpharmaceuticals INC. | $39.59 | 2025 | |
| Philips North America LLC | $38.82 | 2022-2023 | |
| Inari Medical, INC. | $33.41 | 2022 | |
| Janssen Pharmaceuticals, INC | $31.40 | 2022 | |
| Abbott Laboratories | $22.92 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.90 | 2022 | |
| Pfizer INC. | $16.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Shutter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.